IBRUXEN 140 MG
Ibruxen Capsule Ibrutinib 140 mg Everest Pharmaceuticals Ltd. Indications Mantle Cell Lymphoma: Ibrutinib is indicated for the treatment of patients with
JUPARIB 150 MG
Juparib Tablet Olaparib 150 mg Julphar Bangladesh Ltd. Also available as: 100 mg Indications Breast Cancer: Olaparib is indicated as monotherapy
LANVANIX 4
LANVANIX 4/*54745756836*/
LAPANIX 250 MG
LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase
LARONIB 100 MG
DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to
LARONIB 25 MG
DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to
lenvanix-10
lenvanix-10/*54745756836*/
LENVAXEN 10 MG
DESCRIPTION Lenvaxen Lenvatinib 4 mg & 10 mg COMPOSITION LENVAXEN 4 capsules: Each capsule contains Lenvatinib Mesylate INN equivalent to
LENVAXEN 4 MG
DESCRIPTION Lenvaxen Lenvatinib 4 mg & 10 mg COMPOSITION LENVAXEN 4 capsules: Each capsule contains Lenvatinib Mesylate INN equivalent to
LEVAT 10 MG
Levat Capsule Lenvatinib Mesylate 10 mg Julphar Bangladesh Ltd. Indications Lenvatinib is a kinase inhibitor that is indicated: For the treatment
LORBREXEN 100 MG
LORBREXEN 100 MG/*54745756836*/
LUCIBRU 140 MG
LUCIBRU Ibrutinib capsules 140mg 120 capsules Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton’s